Showing 1 - 1 results of 1 for search 'David Mankoff', query time: 0.01s Refine Results
  1. 1
    A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.

    A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine. by Laura Q Chow, Rafael Santana-Davila, Austin Pantel, Mara Roth, Leslie N Anderson, Alan Failor, Robert Doot, David Mankoff

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: